BioSpace News Archive

Hoffmann-La Roche Limited (Roche Canada) is pleased to announce today that Health Canada has granted market authorization to Perjeta® (pertuzumab for injection) as a neoadjuvant treatment of patients with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (either >2 cm in diameter or node positive)

The American Cancer Society is a global grassroots force of nearly 2 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer.

Cleveland based GenomOncology and UH Seidman Cancer Center enter into a market-leading partnership to increase clinical trial accrual rates.

Employment Background Investigations Inc. (EBI), one of the nation’s largest privately-held employee background screening firms, today announces the addition of KINEXON SafeZone to its Workplace Health & Safety solution for distance monitoring and contact tracing.

NavaDerm Partners, LLC (“NavaDerm” or the “Company”), a dermatology platform and portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), announced the appointment of Dr. Roy Geronemus as Chief Executive Officer (“CEO”).

Hospital Alemão Oswaldo Cruz, one of the largest hospital centers in Latin America, has announced a partnership with TriNetX to join the global health research network.

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced that Chief Executive Officer and President Burke T. Barrett will present at the Oppenheimer 31st Annual Healthcare Conference, being held virtually March 16-18, 2021.

Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, today announced it has been named as one of five winners in XPRIZE Rapid COVID Testing for its pioneering SalivaClear™ COVID-19 pooled saliva testing platform.

ResMed announced Rob Douglas, president and chief operating officer and Brett Sandercock, chief financial officer, will participate in a virtual fireside chat at the KeyBanc Capital Markets’ Life Sciences & MedTech Investor Forum on Tuesday, March 23, 2021, beginning at approximately 4:15 p.m.

4D Path, creator of a patented computer-aided cancer diagnostic and precision oncology platform, has extended its existing partnership with the University of Leeds in the UK through 2027, the two organizations announced today.